Publicacións (102) Publicacións nas que participase algún/ha investigador/a


  1. Chitosan-based drug nanocarriers: Where do we stand?

    Journal of Controlled Release, Vol. 161, Núm. 2, pp. 496-504

  2. Chitosan and its derivatives as nanocarriers for siRNA delivery

    Journal of Drug Delivery Science and Technology, Vol. 22, Núm. 1, pp. 29-42

  3. A perspective on the toxicology of marine toxins

    Chemical Research in Toxicology, Vol. 25, Núm. 9, pp. 1800-1804

  4. Chitosan-Based Systems for Mucosal Delivery of Biopharmaceuticals

    Chitosan-Based Systems for Biopharmaceuticals: Delivery, Targeting and Polymer Therapeutics (John Wiley and Sons), pp. 181-209

  5. Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: Implications in drug solubilization and delivery

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 80, Núm. 3, pp. 585-595

  6. Comparative study of toxicological and cell cycle effects of okadaic acid and dinophysistoxin-2 in primary rat hepatocytes

    Life Sciences, Vol. 90, Núm. 11-12, pp. 416-423

  7. Comparative analysis of platelet-derived microparticles reveals differences in their amount and proteome depending on the platelet stimulus

    Journal of Proteomics, Vol. 76, pp. 287-296

  8. Chitosan-based nanocapsules: Physical characterization, stability in biological media and capsaicin encapsulation

    Colloid and Polymer Science, Vol. 290, Núm. 14, pp. 1423-1434

  9. Characterization and activity determination of the human protein phosphatase 2A catalytic subunit α expressed in insect larvae

    Applied Biochemistry and Biotechnology, Vol. 167, Núm. 4, pp. 918-928

  10. Calcium binding proteins

    Advances in Experimental Medicine and Biology, Vol. 740, pp. 461-482

  11. Análisis proteómico de la vía de señalización de CLEC-2 en plaquetas humanas mediante 2-D-DIGE y 2-DE combinado con tinción con SyproRubi: comparación de ambas aproximaciones experimentales

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 8, pp. 115-115

  12. Antiviral properties of polymeric aziridine- and biguanide-modified core-shell magnetic nanoparticles

    Langmuir, Vol. 28, Núm. 9, pp. 4548-4558

  13. Antifouling foldable acrylic IOLs loaded with norfloxacin by aqueous soaking and by supercritical carbon dioxide technology

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 82, Núm. 2, pp. 383-391

  14. Advanced glycation end products: A mysterious shadow beyond the relationship between HbA1c and atrial fibrillation

    International Journal of Cardiology, Vol. 157, Núm. 3, pp. 441

  15. Additional bioactive guanidine alkaloids from the Mediterranean sponge Crambe crambe

    RSC Advances, Vol. 2, Núm. 7, pp. 2828-2835

  16. A vaccine based on biodegradable microspheres induces protective immunity against scuticociliatosis without producing side effects in turbot

    Fish and Shellfish Immunology, Vol. 33, Núm. 1, pp. 21-27

  17. A potential nanomedicine consisting of heparin-Loaded Polysaccharide Nanocarriers for the Treatment of Asthma

    Macromolecular Bioscience, Vol. 12, Núm. 2, pp. 176-183

  18. A detailed proteomic analysis of rhodocytin-activated platelets reveals novel clues on the CLEC-2 signalosome: Implications for CLEC-2 signaling regulation

    Blood, Vol. 120, Núm. 26

  19. 8-Substituted 3-Arylcoumarins as Potent and Selective MAO-B Inhibitors: Synthesis, Pharmacological Evaluation, and Docking Studies

    ChemMedChem, Vol. 7, Núm. 3, pp. 464-470

  20. 3-Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer's disease

    MedChemComm, Vol. 3, Núm. 2, pp. 213-218